Back
AbbVie Vs. Dave Industry Stock Comparison
Sell
48
ABBV
AbbVie
Last Price:
$179.23
Seasonality Move:
-0.85%
Buy
90
DAVE
Dave
Last Price:
$100.46
Seasonality Move:
103.78%
Sell
48
AbbVie (ABBV)
is a Sell
Is AbbVie a Buy, Sell or Hold?
-
ABBV is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
ABBV Stock Price Chart
ABBV Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -1.41 | Sell |
Relative Strength Index (14 RSI): | 54.64 | Buy |
Chaikin Money Flow: | 2295623 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (171.66 - 180.18) | Buy |
Bollinger Bands (100): | (178.1 - 198.12) | Sell |
DAVE Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 5.7 | Buy |
Relative Strength Index (14 RSI): | 60.3 | Buy |
Chaikin Money Flow: | 336947 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (83.31 - 95.25) | Buy |
Bollinger Bands (100): | (30.87 - 76.61) | Buy |
ABBV Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 174.86 | Buy |
20-day SMA: | 176.9 | Buy |
50-day SMA: | 182.27 | Sell |
200-day SMA: | 178.79 | Buy |
8-day EMA: | 176.15 | Buy |
20-day EMA: | 176.53 | Buy |
50-day EMA: | 180.53 | Sell |
200-day EMA: | 178.24 | Buy |
DAVE Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 93.41 | Buy |
20-day SMA: | 90.93 | Buy |
50-day SMA: | 69.71 | Buy |
200-day SMA: | 46.28 | Buy |
8-day EMA: | 91.77 | Buy |
20-day EMA: | 88.14 | Buy |
50-day EMA: | 74.64 | Buy |
200-day EMA: | 48.61 | Buy |
AbbVie Earnings Growth & ABBV Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.29 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.19 per share, and an increase next year of $1.24 per share.
Dave Earnings Growth & DAVE Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.65 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and an increase next year of $0.78 per share.
AbbVie Technical Analysis
Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | Dec 23 | Dec 24 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | 23 | 24 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Dave Technical Analysis
Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | Dec 23 | Dec 24 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | 23 | 24 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |